10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)
Clinical trial NCT00885612 · COMPLETED
Trial details
- NCT number
- NCT00885612
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-05-01
- Primary completion
- 2010-03-01
- Enrollment
- 1114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.